BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16926132)

  • 1. The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
    Shah YB; Priore SF; Li Y; Tang CN; Nicholas P; Kurre P; Olson TS; Babushok DV
    Blood Adv; 2021 Aug; 5(16):3216-3226. PubMed ID: 34427585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to the diagnosis of aplastic anemia.
    DeZern AE; Churpek JE
    Blood Adv; 2021 Jun; 5(12):2660-2671. PubMed ID: 34156438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti.
    Hosokawa K; Nakao S
    Ann Hematol; 2022 Feb; 101(2):461-464. PubMed ID: 33904954
    [No Abstract]   [Full Text] [Related]  

  • 4. Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit Engraftment.
    DeZern AE; Jones RJ; Brodsky RA
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):e26-e30. PubMed ID: 30055352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic problems in acquired bone marrow failure syndromes.
    Nakao S
    Int J Hematol; 2016 Aug; 104(2):151-2. PubMed ID: 27380193
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
    Narita A; Kojima S
    Int J Hematol; 2016 Aug; 104(2):153-8. PubMed ID: 27091471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and evolution of paroxysmal nocturnal hemoglobinuria clones in patients with acquired aplastic anemia].
    Zhang J; Li X; Shi J; Ge M; Shao Y; Huang J; Huang Z; Nie N; Zheng Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):124-9. PubMed ID: 27014982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
    DeZern AE; Brodsky RA
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.
    DeZern AE; Sekeres MA
    Oncologist; 2014 Jul; 19(7):735-45. PubMed ID: 24899643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes.
    DeZern AE; Symons HJ; Resar LS; Borowitz MJ; Armanios MY; Brodsky RA
    Eur J Haematol; 2014 Jun; 92(6):467-70. PubMed ID: 24612308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.
    Asimakopoulos JV; Terpos E; Papageorgiou L; Kampouropoulou O; Christoulas D; Giakoumis A; Samarkos M; Vaiopoulos G; Konstantopoulos K; Angelopoulou MK; Vassilakopoulos TP; Meletis J
    Med Sci Monit; 2014 Jan; 20():123-39. PubMed ID: 24463881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia.
    Sakamoto T; Obara N; Kurita N; Sakata-Yanagimoto M; Nishikii H; Yokoyama Y; Suzukawa K; Hasegawa Y; Chiba S
    Int J Hematol; 2013 Sep; 98(3):319-22. PubMed ID: 23963878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of telomere attrition in patients with aplastic anemia.
    Scheinberg P
    Int J Hematol; 2013 May; 97(5):553-7. PubMed ID: 23636667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Border between aplastic anemia and myelodysplastic syndrome.
    Yamazaki H; Nakao S
    Int J Hematol; 2013 May; 97(5):558-63. PubMed ID: 23613266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
    Battiwalla M; Hepgur M; Pan D; McCarthy PL; Ahluwalia MS; Camacho SH; Starostik P; Wallace PK
    Cytometry B Clin Cytom; 2010 Sep; 78(5):348-56. PubMed ID: 20533383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
    Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
    Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of a small population of paroxysmal nocturnal hemoglobinuria-type cells in the management of bone marrow failure.
    Nakao S; Sugimori C; Yamazaki H
    Int J Hematol; 2006 Aug; 84(2):118-22. PubMed ID: 16926132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome.
    Wang H; Chuhjo T; Yasue S; Omine M; Nakao S
    Blood; 2002 Dec; 100(12):3897-902. PubMed ID: 12393738
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.